fda compounded tirzepatide warning 2024 2025 versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, the drugmaker said Compound versions of GLP-1 drugs
Description
Tirzepatide can be taken at any time of day, with or without food
Plaintiffs in ongoing lawsuits argue that they were not properly warned about the risk of persistent stomach paralysis or other severe outcomes
These cases maintain temperatures in the acceptable range for 12 to 24 hours depending on ambient conditions
The barriers are lower than most people expect, and getting started typically takes far less time than a traditional specialist appointment
